ALK-B vs ASND: Side-by-Side Comparison
Compare ALK-Abelló A/S (ALK-B) and Ascendis Pharma A/S (ASND) side by side: market cap DKK 54.11B vs USD 16.96B, P/E 42.0 vs 30.9. Financials, growth and model signals on Bullrun.
| Metric | ALK-B | ASND |
|---|---|---|
| Company | ALK-Abelló A/S | Ascendis Pharma A/S |
| Country / Exchange | Denmark · CO | Denmark · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | DKK 54.11B | USD 16.96B |
| P/E ratio | 42.0 | 30.9 |
| Dividend yield | 0.66% | — |
| Valuation model | 6.2% overvalued | 85.7% undervalued |
| Revenue (latest FY) | DKK 6.31B | — |
| Revenue growth YoY | +14.0% | — |
| Net income | DKK 1.20B | — |
| Gross margin | 67.1% | — |
| Diluted EPS | 540.00 | — |